Status:
COMPLETED
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Precancerous Condition
Eligibility:
FEMALE
21-120 years
Phase:
NA
Brief Summary
RATIONALE: Polyunsaturated fatty acids are important for normal growth and development. One type, called omega-3 fatty acids (found in fish, fish oil, and some other foods), may affect the growth of a...
Detailed Description
OBJECTIVES: * To determine the effect of omega-3 fatty acids on markers of breast cancer progression in women with newly diagnosed ductal carcinoma in situ and/or atypical ductal hyperplasia. * To de...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Biopsy confirmed diagnosis of any of the following:
- Ductal carcinoma in situ (DCIS) and/or atypical ductal hyperplasia (ADH)
- DCIS with a component of invasive carcinoma
- ADH with a component of invasive carcinoma
- DCIS and ADH with a component of invasive carcinoma
- Newly diagnosed disease
- No pure invasive breast cancer on biopsy without a component of DCIS or ADH
- Hormone receptor status not specified
- PATIENT CHARACTERISTICS:
- Female
- Menopausal status not specified
- Not pregnant
- Negative pregnancy test
- Speaks English or Spanish
- No allergy to fish oil or olive oil
- No condition that, in the opinion of the study clinician, would make participation in the study harmful to the patient
- PRIOR CONCURRENT THERAPY:
- No concurrent therapeutic anticoagulation
- No concurrent use of fish oil \> 1 g/day
Exclusion
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00627276
Start Date
December 1 2007
End Date
November 1 2013
Last Update
April 27 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Epic Imaging
Portland, Oregon, United States, 97220
2
Knight Cancer Institute at Oregon Health and Science University
Portland, Oregon, United States, 97239-3098